Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Conditioned medium of periodontal ligament mesenchymal stem cells exert anti-inflammatory effects in lipopolysaccharide-activated mouse motoneurons.
Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice.
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury.
Diagnostic Criteria for Psychosomatic Research and Psychosocial Functioning in Multiple Sclerosis.
Specialist nursing in MS - the way forward: key elements for developing MS specialist nurse services in the UK.
Knowing what's right: Which analgesic is recommended for a patient suffering from demyelinating polyneuropathy and scheduled for rotator-cuff repair?
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases.
Multiple Sclerosis Patients Valuing Their Own Health Status: Valuation and Psychometric Properties of the 15D.
Assessment of 1,25-dihydroxyvitamin D3 effects on Treg cells in a mouse model of systemic lupus erythematosus.
Acute ganglion cell loss during rapid visual recovery in optic neuritis.
Angiotensin-(1-7) Protects from Brain Damage Induced by Shiga Toxin 2-Producing Enterohemorrhagic Escherichia Coli.
Linc-MAF-4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.
Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.
Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.
Port-to-port delivery: Mobilization of toxic sphingolipids via extracellular vesicles.
Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the United States.
Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions.
Observational data: Understanding the real MS world.
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - Commentary.
What you get from what you see: Parametric assessment of visual processing capacity in multiple sclerosis and its relation to cognitive fatigue.
Poster 353 Acute Onset Chronic Inflammatory Demyelinating Polyneuropathy (A-CIDP) with CNS Involvement Initially Diagnosed as Guillain-Barre Syndrome (GBS): A Case Report.
Glial Cells and Integrity of the Nervous System.
Are electrophysiological criteria useful in distinguishing childhood demyelinating neuropathies?
Donepezil promotes differentiation of neural stem cells into mature oligodendrocytes at the expense of astrogenesis.

Pages